TriangleNCT01023308 · OUTCOME
Progression Free Survival in Patients Treated With Panobinostat in Combination With Bortezomib and Dexamethasone vs. Patients Treated by Placebo in Combination With Bortezomib and Dexamethasone.
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEDIAN
- Unit
- months
- Interval / dispersion
- 95% Confidence Interval
- Time frame
- 45 months
Analysis population: Full Analysis Set
Groups in this outcome
Panobinostat + Bortezomib
Panobinostat was given 20 mg hard gelatin capsules . Bortezomib was given at 1.3 mg/m2 as a 3 to 5 second bolus intravenous (IV)injection. Dexamethasone was given as an oral dose of 20 mg/day.
Placebo + Bortezomib
Placebo was given as a hard gelatin capsule in the image of Panobinostat . Bortezomib was given at 1.3 mg/m2 as a 3 to 5 second bolus intravenous (IV) injection. Dexamethasone was given as an oral dose of 20 mg/day.
| Group | Source count |
|---|---|
| Panobinostat + Bortezomib | 387 |
| Placebo + Bortezomib | 381 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Panobinostat + Bortezomib | 11.99 | Not reported | 10.32 | 12.94 | Not reported |
| Placebo + Bortezomib | 8.80 | Not reported | 7.56 | 9.23 | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 10.32
- upper Limit
- 12.94
- value
- 11.99
- group Id
- OG001
- lower Limit
- 7.56
- upper Limit
- 9.23
- value
- 8.80
- denoms
- counts
- group Id
- OG000
- value
- 387
- group Id
- OG001
- value
- 381
- units
- Participants
- dispersion Type
- 95% Confidence Interval
- groups
- description
- Panobinostat was given 20 mg hard gelatin capsules . Bortezomib was given at 1.3 mg/m2 as a 3 to 5 second bolus intravenous (IV)injection. Dexamethasone was given as an oral dose of 20 mg/day.
- id
- OG000
- title
- Panobinostat + Bortezomib
- description
- Placebo was given as a hard gelatin capsule in the image of Panobinostat . Bortezomib was given at 1.3 mg/m2 as a 3 to 5 second bolus intravenous (IV) injection. Dexamethasone was given as an oral dose of 20 mg/day.
- id
- OG001
- title
- Placebo + Bortezomib
- param Type
- MEDIAN
- population Description
- Full Analysis Set
- reporting Status
- POSTED
- time Frame
- 45 months
- title
- Progression Free Survival in Patients Treated With Panobinostat in Combination With Bortezomib and Dexamethasone vs. Patients Treated by Placebo in Combination With Bortezomib and Dexamethasone.
- type
- PRIMARY
- unit Of Measure
- months
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice